TARGET Intracranial Aneurysm Coiling Registry
(TARGET Trial)
Recruiting in Palo Alto (17 mi)
+8 other locations
Overseen byOsama O Zaidat, MD, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Mercy Health Ohio
No Placebo Group
Trial Summary
What is the purpose of this trial?The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.
Eligibility Criteria
Inclusion Criteria
Patient is 18 years or older.
Patient has a documented, previously untreated, saccular intracranial aneurysm, unruptured or ruptured, suitable for embolization with coils.
(NEW NANO arm ONLY) Target aneurysm is ≤7mm.
+4 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Target 360°, 2D, Nano CoilsExperimental Treatment1 Intervention
Subjects will undergo embolization using Target 360°, 2D, Nano Coils for the treatment of their intracranial aneurysm.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Greenville Health SystemGreenville, SC
University of Massachusetts Medical SchoolWorcester, MA
McLaren HealthFlint, MI
Mercy Health St. Vincent Medical CenterToledo, OH
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Mercy Health OhioLead Sponsor
Stryker NeurovascularIndustry Sponsor